|Date: 26 July (Friday) 09:00 – 12:00
Venue: 3F, Bldg. A, CTBC Financial Park, Ballroom A
Cell & Gene Therapy
Gene and cell therapies are developing at a rapid pace, spearheaded by the 2017 US approval of Luxturna, the first directly administered gene therapy. Immunotherapies are also new to the game but equally exciting; with CAR-T the star of a growing number of near miracle-level cancer remissions, this treatment category is poised to upend the field of oncology as we know it. With regulators struggling to keep up with these fast-evolving technologies, particularly in Asia, strap into your seats as this session takes on the very latest trends and developments in these cutting-edge therapies.